Pfizer Inc. (NYSE:PFE)

The financial performance, as indicated by Return on Assets (ROA), Financial Leverage, and Return on Equity (ROE), exhibits considerable fluctuation over the analyzed period. Initially, a positive trend is observed in both ROA and ROE, followed by a marked decline, and then a period of stabilization with some volatility.

Return on Assets (ROA)

ROA demonstrates an initial increase from 13.58% in April 2022 to a peak of 15.91% in December 2022. Subsequently, a significant downward trend emerges, with ROA decreasing to 0.94% by December 2023 and reaching a low of -0.33% in December 2024. A modest recovery is then observed, rising to 3.76% in December 2024 and 3.73% in December 2025. This suggests a weakening, then partial recovery, in the efficiency of asset utilization in generating earnings.

Financial Leverage

Financial Leverage remains relatively stable between April 2022 and October 2023, fluctuating between 1.94 and 2.24. A noticeable increase is then observed, peaking at 2.54 in December 2023, before decreasing to 2.25 in September 2025. This indicates a changing reliance on debt financing, with a period of increased leverage followed by a slight reduction. The overall level of leverage remains consistent, suggesting a deliberate capital structure management approach.

Return on Equity (ROE)

ROE mirrors the trend observed in ROA, initially increasing from 30.29% to 33.61% before declining substantially. The most significant drop occurs between July 2023 and December 2024, with ROE falling from 21.68% to -2.96%. A recovery is then evident, reaching 8.99% by December 2025. The correlation between ROA and ROE is strong, as expected, given the influence of ROA on ROE through the DuPont formula. The negative ROE value in December 2024 indicates a period where the company generated insufficient profit relative to shareholder equity.

ROE Decomposition

The decline in ROE is primarily driven by the substantial decrease in ROA. While Financial Leverage initially provides some amplification to ROE, its impact is limited by the declining profitability of assets. The increase in Financial Leverage in late 2023 and early 2024 does not fully offset the negative impact of the falling ROA, contributing to the negative ROE observed in December 2024. The subsequent recovery in ROE is a result of both a slight improvement in ROA and a stabilization of Financial Leverage.

In summary, the period under review demonstrates a shift in financial performance. Initial strength gives way to a period of significant decline, followed by a tentative stabilization. The primary driver of this performance is the efficiency of asset utilization, as reflected in ROA, with Financial Leverage playing a secondary, moderating role.

The three-component DuPont analysis reveals significant fluctuations in Return on Equity (ROE) over the observed period. These fluctuations are driven by changes in Net Profit Margin, Asset Turnover, and Financial Leverage. A general trend of declining performance is evident, particularly in the latter half of the period, though some quarters show improvement.

Net Profit Margin

The Net Profit Margin demonstrates a strong upward trend from April 2022 to December 2022, peaking at 31.27%. However, a substantial decline is then observed, reaching a low of -4.62% in June 2024. A recovery is noted in subsequent quarters, reaching 16.84% in June 2025, but remains below the levels seen in early 2022. This volatility significantly impacts overall ROE.

Asset Turnover

Asset Turnover exhibits a relatively stable pattern initially, fluctuating around 0.50 to 0.52 between April 2022 and December 2022. A consistent downward trend emerges from April 2023, reaching a low of 0.26 in December 2023. While a slight recovery is seen in subsequent quarters, peaking at 0.31 in June 2025, it does not return to the levels observed earlier in the period. This decline suggests decreasing efficiency in utilizing assets to generate sales.

Financial Leverage

Financial Leverage generally decreases from 2.23 in April 2022 to 1.94 in April 2023, before increasing again. A notable increase is observed from October 2023, peaking at 2.54 in December 2023. Leverage remains elevated through March 2025, before decreasing slightly to 2.25 in September 2025 and increasing again to 2.41 in December 2025. The impact of leverage on ROE is amplified by the fluctuations in Net Profit Margin and Asset Turnover.

The combined effect of these three components results in a corresponding decline in ROE. ROE peaked at 33.61% in July 2022, but experienced a significant decrease, reaching negative values in March 2024 (-0.33%) and June 2024 (-2.96%). While ROE shows some recovery in later quarters, reaching 12.12% in June 2025, it remains considerably lower than the levels observed in the earlier part of the analyzed period. The substantial decline in Net Profit Margin appears to be the primary driver of the ROE decrease, although the falling Asset Turnover also contributes significantly.

The observed trends suggest a weakening of profitability and asset utilization, partially offset by changes in financial leverage. Continued monitoring of these ratios is recommended to assess the sustainability of any recovery and to identify the underlying causes of the observed performance changes.

The financial performance, as indicated by the two-component disaggregation of Return on Assets (ROA), reveals a dynamic period with significant fluctuations over the observed timeframe. Initially, both Net Profit Margin and Asset Turnover contributed to a generally positive ROA, but subsequent periods demonstrate a marked decline in both components, culminating in a period of negative ROA before a partial recovery.

Net Profit Margin

The Net Profit Margin exhibited a consistent upward trend from April 2022 to December 2022, peaking at 31.27%. Following this peak, the margin experienced a substantial and rapid decline, reaching a low of -4.62% in December 2023. A subsequent recovery is observed, with the margin reaching 16.84% by June 2025, though it remains below the levels seen in early 2022. This suggests increasing cost pressures or declining revenue strength in late 2023 and early 2024, followed by some improvement.

Asset Turnover

Asset Turnover demonstrated relative stability between April 2022 and December 2022, fluctuating around 0.50. A clear downward trend commenced in early 2023, with the ratio declining to 0.26% by December 2023. While the ratio experienced a modest recovery, reaching 0.31 by June 2025, it has not returned to the levels observed in the earlier part of the period. This indicates a decreasing efficiency in utilizing assets to generate revenue.

Return on Assets (ROA)

The ROA mirrored the combined effect of the Net Profit Margin and Asset Turnover. It peaked at 15.91% in December 2022, then experienced a significant decline, falling to 0.94% by December 2023 and even becoming negative (-0.14%) in March 2024. A gradual recovery is evident in subsequent periods, with the ROA reaching 3.73% by December 2025. The negative ROA in early 2024 highlights a period where the company’s assets were not generating sufficient profit.

The correlation between the declining Net Profit Margin and Asset Turnover is strong, suggesting that the decrease in ROA is attributable to both reduced profitability and decreased efficiency in asset utilization. The partial recovery observed in the latter part of the period indicates some positive momentum, but the ROA remains significantly below its earlier peak.